|
South Carolina adopts positive coverage of Aerocrine's FeNO testing in …
CisionWire (press release) Physicians use FeNO to assess eosinophilic airway inflammation, the primary underlying abnormality that affects the airways of individuals who have asthma. NIOX MINO is the only product of its kind currently on the market for assessing FeNO. |
View full post on asthma – Google News